OR WAIT null SECS
April 02, 2016
Manufacturing highly toxic compounds in a biopharmaceutical environment tests equipment and systems.
A global API marketplace increases the burden of supply chain monitoring for drug companies.
April 01, 2016
Unsafe material may remain in the US supply chain, according to a March 29th letter to FDA Commissioner Califf
March 29, 2016
Novo Nordisk broke ground on a facility in Clayton, NC, to manufacture APIs for GLP-1 and insulin medicines.
March 24, 2016
Collaboration will provide for unified development and manufacture of antibody drug conjugates.
March 15, 2016
The authors present analysis of the state of control of intermediate identity and quality, based on analysis of recently submitted DMFs.
March 02, 2016
Asking the right questions is crucial to establishing a biopharmaceutical facility design.
Gauging the adequate level and type of screening is the challenge when identifying relevant crystalline forms.
Hazardous reagents can prove to be faster, simpler, cheaper, and greener.
February 24, 2016
ICIG’s CordenPharma Group expands fermentation-based production technology with acquisition of Sandoz Site.